Zobrazeno 1 - 10
of 8 640
pro vyhledávání: '"cancer vaccine"'
Autor:
Wei-Yu Chi, Yingying Hu, Hsin-Che Huang, Hui-Hsuan Kuo, Shu-Hong Lin, Chun-Tien Jimmy Kuo, Julia Tao, Darrell Fan, Yi-Min Huang, Annie A. Wu, Chien-Fu Hung, T.-C. Wu
Publikováno v:
Journal of Biomedical Science, Vol 31, Iss 1, Pp 1-26 (2024)
Abstract Recent breakthroughs in cancer immunotherapies have emphasized the importance of harnessing the immune system for treating cancer. Vaccines, which have traditionally been used to promote protective immunity against pathogens, are now being e
Externí odkaz:
https://doaj.org/article/b6d7c42b430b40cd836bcbed8017c46d
Publikováno v:
European Journal of Medical Research, Vol 29, Iss 1, Pp 1-56 (2024)
Abstract Parasites have attained a life-long stigma of being detrimental organisms with deleterious outcomes. Yet, recently, a creditable twist was verified that can dramatically change our perception of those parasites from being a source of misery
Externí odkaz:
https://doaj.org/article/9df6b3df6ae84e358c26195302d98dd3
Autor:
Ying Zhou, Rui Wei, Ling Wang, Jie Li, Wei Wang, Guiying Jiang, Songwei Tan, Fei Li, Xueqian Wang, Xiangyi Ma, Ling Xi
Publikováno v:
Journal of Nanobiotechnology, Vol 22, Iss 1, Pp 1-14 (2024)
Abstract The mortality of ovarian cancer (OC) has long been the highest among gynecological malignancies. Although OC is considered to be an immunogenic tumor, the effect of immunotherapy is not satisfactory. The immunosuppressive microenvironment is
Externí odkaz:
https://doaj.org/article/e2e3e87938424ace8370d7856414fc02
Publikováno v:
Molecular Oncology, Vol 18, Iss 8, Pp 1821-1848 (2024)
Chimeric antigen receptor (CAR‐T) cell therapy is a newly developed immunotherapy strategy and has achieved satisfactory outcomes in the treatment of hematological malignancies. However, some adverse effects related to CAR‐T cell therapy have to
Externí odkaz:
https://doaj.org/article/5ddb3b9aaf9a43698be3efd5e0037666
Publikováno v:
Bioactive Materials, Vol 43, Iss , Pp 67-81 (2025)
Current cancer immunotherapies exhibit low response rates attributed to suppressive tumor immune microenvironments (TIMEs). To address these unfavorable TIMEs, supplementation with tumor-associated antigens and stimulation of immune cells at target s
Externí odkaz:
https://doaj.org/article/16b41c844354444d8ee26737a7e2e4d7
Publikováno v:
Expert Review of Vaccines, Vol 23, Iss 1, Pp 205-212 (2024)
ABSTRACTIntroduction Clinical trials of personalized cancer vaccines have shown that on-demand therapies that are manufactured for each patient, result in activated T cell responses against individual tumor neoantigens. However, their use has been tr
Externí odkaz:
https://doaj.org/article/c49a5329643540508e3c44e5426a9e1f
Autor:
Jie Zheng, Xingxian Li, Anna Maria Masci, Hayleigh Kahn, Anthony Huffman, Eliyas Asfaw, Yuanyi Pan, Jinjing Guo, Virginia He, Justin Song, Andrey I. Seleznev, Asiyah Yu Lin, Yongqun He
Publikováno v:
Journal of Biomedical Semantics, Vol 15, Iss 1, Pp 1-13 (2024)
Abstract Background The exploration of cancer vaccines has yielded a multitude of studies, resulting in a diverse collection of information. The heterogeneity of cancer vaccine data significantly impedes effective integration and analysis. While CanV
Externí odkaz:
https://doaj.org/article/96ae78423e8c4891b41ccbc5afa2b3ad
Autor:
Lei-Ming Cao, Yi-Fu Yu, Zi-Zhan Li, Nian-Nian Zhong, Guang-Rui Wang, Yao Xiao, Bing Liu, Qiu-Ji Wu, Chun Feng, Lin-Lin Bu
Publikováno v:
Journal of Nanobiotechnology, Vol 22, Iss 1, Pp 1-14 (2024)
Abstract Research into mRNA vaccines is advancing rapidly, with proven efficacy against coronavirus disease 2019 and promising therapeutic potential against a variety of solid tumors. Adjuvants, critical components of mRNA vaccines, significantly enh
Externí odkaz:
https://doaj.org/article/296ef2e8934648d985c1eb56474124e5
Publikováno v:
Waike lilun yu shijian, Vol 29, Iss 03, Pp 264-269 (2024)
Colorectal cancer(CRC) ranks in third place in terms of incidence but second in terms of mortality. Cancer vaccine, as a novel immunotherapy, presents tumor antigens to human immune system and further elicits anti-tumor immune response, leading to lo
Externí odkaz:
https://doaj.org/article/4095158bef844a35b74c4531b628fc50
Publikováno v:
Experimental Hematology & Oncology, Vol 13, Iss 1, Pp 1-20 (2024)
Abstract Hematological malignancies (HMs) encompass a diverse group of blood neoplasms with significant morbidity and mortality. Immunotherapy has emerged as a validated and crucial treatment modality for patients with HMs. Despite notable advancemen
Externí odkaz:
https://doaj.org/article/e2f65346268a4085ac837af094ac62af